Aquestive Therapeutics Ownership | Who Owns Aquestive Therapeutics?
Aquestive Therapeutics Ownership Summary
Aquestive Therapeutics is owned by 57.67% institutional investors, 5.01% insiders, and 37.32% retail investors. Bratton capital management is the largest institutional shareholder, holding 13.33% of AQST shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.64% of its assets in Aquestive Therapeutics shares.
AQST Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Aquestive Therapeutics | 57.67% | 5.01% | 37.32% |
Sector | Healthcare Stocks | 47.31% | 8.01% | 44.69% |
Industry | Specialty & Generic Drug Manufacturers Stocks | 33.38% | 9.20% | 57.42% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Bratton capital management | 9.81M | 13.33% | $25.51M |
Vr adviser | 5.56M | 7.55% | $14.44M |
Blackrock | 5.45M | 7.41% | $14.18M |
Vanguard group | 4.23M | 5.74% | $10.99M |
Franklin resources | 2.85M | 3.88% | $7.42M |
Geode capital management | 1.58M | 2.14% | $4.10M |
Blue owl capital lp | 1.14M | 1.55% | $2.96M |
State street | 984.06K | 1.34% | $2.56M |
Janney montgomery scott | 880.49K | 1.20% | $2.29M |
Nuveen asset management | 785.02K | 1.07% | $2.04M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Bratton capital management | 9.81M | 100.00% | $25.51M |
Vr adviser | 5.56M | 0.92% | $14.44M |
Blue owl capital lp | 1.14M | 0.82% | $2.96M |
Latash investments | 243.13K | 0.51% | $632.15K |
Essex investment management | 705.18K | 0.34% | $1.83M |
Diametric capital, lp | 242.71K | 0.34% | $631.05K |
Dafna capital management | 530.00K | 0.33% | $1.38M |
Bracebridge capital | 428.57K | 0.20% | $1.11M |
Cahill wealth management | 118.56K | 0.18% | $308.26K |
Legato capital management | 242.37K | 0.08% | $630.16K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 5.45M | 0.00% | 4.11M |
Geode capital management | 1.58M | 0.00% | 1.04M |
Vanguard group | 4.23M | 0.00% | 985.10K |
State street | 984.06K | 0.00% | 802.42K |
Nuveen asset management | 785.02K | 0.00% | 785.02K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Laurion capital management lp | - | - | -1.55M |
Monashee investment management | - | - | -1.00M |
Renaissance | 496.20K | 0.00% | -879.60K |
Invesco | 89.04K | - | -808.47K |
Ghost tree capital | - | - | -702.94K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Nuveen asset management | 785.02K | 0.00% | 785.02K | $2.04M |
Deerfield management company, l.p. (series c) | 146.16K | 0.01% | 146.16K | $380.00K |
Rhumbline advisers | 97.84K | 0.00% | 97.84K | $254.37K |
Alliancebernstein | 41.28K | - | 41.28K | $107.33K |
Corebridge financial | 39.95K | 0.00% | 39.95K | $104.28K |
Sold Out
Holder | Change |
---|---|
Highmark wealth management | -50.00 |
Headlands | -269.00 |
Creative financial designs inc /adv | -700.00 |
Federated hermes | -1.40K |
Macquarie group | -3.71K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 99 | -3.88% | 42,456,890 | 2.32% | 57 | 1.26% | 60 | -18.92% | 23 | 64.29% |
Mar 31, 2024 | 103 | 68.85% | 41,494,848 | 74.43% | 67 | 5.01% | 74 | 131.25% | 14 | 7.69% |
Dec 31, 2023 | 61 | 17.31% | 23,788,793 | 3.91% | 36 | 2.31% | 32 | 68.42% | 13 | - |
Sep 30, 2023 | 52 | -8.77% | 22,893,946 | 20.01% | 39 | 3.39% | 19 | -54.76% | 13 | 550.00% |
Jun 30, 2023 | 57 | 58.33% | 19,076,504 | 27.72% | 34 | 4.76% | 42 | 180.00% | 2 | -71.43% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 2.40M | 2.64% | - |
iShares Russell 2000 ETF | 1.92M | 2.11% | -4.31K |
Franklin Biotechnology Discv A(acc)USD | 1.77M | 1.95% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 1.12M | 1.23% | -108.38K |
Franklin Biotechnology Discovery A | 993.80K | 1.09% | - |
Fidelity Small Cap Index | 760.52K | 0.84% | -18.73K |
Invesco Dorsey Wright SmallCap Momt ETF | 748.44K | 0.82% | - |
Nuveen Equity Index R6 | 649.35K | 0.71% | - |
iShares Russell 2000 Value ETF | 512.89K | 0.56% | - |
State St Russell Sm/Mid Cp® Indx NL Cl C | 441.98K | 0.48% | -15.30K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 15, 2024 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sell | $300.00K |
Mar 08, 2024 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sell | $129.69K |
Jun 14, 2022 | Boyd Peter E. | SVP-Bus. Process & Info. Tech. | Buy | $4.05K |
Jun 08, 2022 | Barber Daniel | Chief Executive Officer | Buy | $88.07K |
Jun 08, 2022 | Barber Daniel | Chief Executive Officer | Buy | $88.07K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | - | - |
2024 Q1 | - | 2 |
2023 Q3 | - | - |
2023 Q2 | - | - |
2023 Q1 | - | - |
AQST Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools